Concepedia

James R. Berenson

JR

165

Publications

18.4K

Citations

61

H-Index

1967

Active since

Affiliations

Institute for Myeloma & Bone Cancer Research(Current)

Oncotherapeutics (United States)

Cedars-Sinai Medical Center

University of California, Los Angeles

West Los Angeles College

James R. Berenson is an author at Institute for Myeloma & Bone Cancer Research specializing in medicine, immunology, and hematology.

ORCID

Top concepts

Publications per year

1967–2022

165

Publications

165

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

James R. Berenson, Alan Lichtenstein, Lester Porter et al. · New England Journal of Medicine · 1996 · 1.1K citations

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

Sundar Jagannath, Bart Barlogie, James R. Berenson et al. · British Journal of Haematology · 2004 · 739 citations · Full text

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

James R. Berenson, Alan Lichtenstein, Lisa A. Porter et al. · Journal of Clinical Oncology · 1998 · 652 citations

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Paul G. Richardson, Hannah Briemberg, Sundar Jagannath et al. · Journal of Clinical Oncology · 2006 · 644 citations · Full text

Rows per page

1–5 of 165